Skip to main content
Log in

Improving access to hepatitis C treatment in Pakistan: important role of generics

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ali S, et al. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme. International Journal of Clinical Pharmacy : 28 Nov 2020. Available from: URL: http://doi.org/10.1007/s11096-020-01202-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Improving access to hepatitis C treatment in Pakistan: important role of generics. PharmacoEcon Outcomes News 868, 21 (2020). https://doi.org/10.1007/s40274-020-7353-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7353-9

Navigation